NCT07130981 Body Composition and Psychosocial Factors in ICI-Treated Cancer Patients
| NCT ID | NCT07130981 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2025-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2025-09-01 with a primary completion date of 2025-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Evaluation of the effects of body composition, psychosocial factors, and drug-related problems on clinical progression (such as toxicity, treatment response, and quality of life) in cancer patients treated with immune checkpoint inhibitors
Eligibility Criteria
Inclusion Criteria: * Aged 18 years or older * Having undergone a CT scan (at the L3 level) prior to treatment * No severe mental disorder and able to communicate effectively * Provided written informed consent Exclusion Criteria: * Did not provide written informed consent * Patients deemed unsuitable by the physician
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07130981 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07130981 currently recruiting?
Yes, NCT07130981 is actively recruiting participants. Contact the research team at izgibayraktar@gmail.com for enrollment information.
Where is the NCT07130981 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT07130981 clinical trial?
NCT07130981 is sponsored by Hacettepe University. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.